Neurogene
NGNE
NGNE
93 hedge funds and large institutions have $340M invested in Neurogene in 2025 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 29 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 88 → 93 (+5)
0.64% less ownership
Funds ownership: 107.2% → 106.56% (-0.64%)
17% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 29
Holders
93
Holding in Top 10
2
Calls
$206K
Puts
$39K
Top Buyers
| 1 | +$9.07M | |
| 2 | +$4.85M | |
| 3 | +$4M | |
| 4 |
Jennison Associates
New York
|
+$3.46M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.48M |
Top Sellers
| 1 | -$4.39M | |
| 2 | -$4.37M | |
| 3 | -$2.41M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.25M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.83M |
